Midgard Science

Klyne

San Francisco, CA, United States klyne.ai From their website, Nov 2026

Work here? Claim this listing

About

Klyne provides AI-powered in silico drug discovery services for startups and academic labs, focused on hit discovery and hit-to-lead optimization. It works in computational drug discovery and molecular prediction for a wide array of drug targets.

Services

  • Ultra-large virtual screening

    Screens billions of compounds to maximize hit rates for hit discovery.

  • Active learning screening

    Uses active learning to reduce compute while maintaining screening accuracy.

  • KlyneDock

    ML-enhanced docking intended to reduce false positives in virtual screening.

  • HYRDA

    Molecular dynamics-driven affinity prediction described as FEP-like accuracy at lower cost.

  • Klyne FEP

    Free-energy perturbation service for affinity prediction and lead optimization.

  • GenAI optimization

    Generative AI tools for multi-parameter optimization, including selectivity and ADMET prediction.

  • Gen-AI lead optimization

    Uses generative AI to optimize selectivity, ADMET, and analog design during hit-to-lead refinement.

Turnaround
  • Reliable results in days
  • Days

Capabilities

Assays and studies
  • Virtual screening
  • Molecular docking
  • Free-energy perturbation
  • Affinity prediction
  • ADMET prediction
  • Free energy perturbation
Scale and capacity
  • Billions of compounds
  • Billions of molecules
  • 33 billion compounds

Modalities and species

Species and models
Molecular targets

Industries served

  • Drug discovery

Details

Type
CRO
Based in
San Francisco, CA, United States

Similar labs